BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29623674)

  • 1. Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions.
    Chen EB; Cason C; Gilbert JA; Ho KJ
    J Gastrointest Surg; 2018 Jun; 22(6):1112-1123. PubMed ID: 29623674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Disease and the Gut Microbiome: What a Surgeon Needs to Know.
    Rahman S; Lu E; Patel RK; Tsikitis VL; Martindale RG
    Surg Clin North Am; 2024 Jun; 104(3):647-656. PubMed ID: 38677827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modulation of the intestinal microbiota by nutritional interventions].
    Derer S; Lehnert H; Sina C; Wagner AE
    Internist (Berl); 2017 May; 58(5):435-440. PubMed ID: 28283691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the gut microbiome and its metabolites in metabolic diseases.
    Wu J; Wang K; Wang X; Pang Y; Jiang C
    Protein Cell; 2021 May; 12(5):360-373. PubMed ID: 33346905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
    Kirpich IA; Marsano LS; McClain CJ
    Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interindividual variability in gut microbiota and host response to dietary interventions.
    Healey GR; Murphy R; Brough L; Butts CA; Coad J
    Nutr Rev; 2017 Dec; 75(12):1059-1080. PubMed ID: 29190368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiota and host health: a new clinical frontier.
    Marchesi JR; Adams DH; Fava F; Hermes GD; Hirschfield GM; Hold G; Quraishi MN; Kinross J; Smidt H; Tuohy KM; Thomas LV; Zoetendal EG; Hart A
    Gut; 2016 Feb; 65(2):330-9. PubMed ID: 26338727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease.
    Yang YJ; Ni YH
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S55-S61. PubMed ID: 30509561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.
    Jayakumar S; Loomba R
    Aliment Pharmacol Ther; 2019 Jul; 50(2):144-158. PubMed ID: 31149745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human gut microbiome: implications for future health care.
    Kinross JM; von Roon AC; Holmes E; Darzi A; Nicholson JK
    Curr Gastroenterol Rep; 2008 Aug; 10(4):396-403. PubMed ID: 18627653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria.
    Schwenger KJP; Bolzon CM; Li C; Allard JP
    Eur J Nutr; 2019 Aug; 58(5):1771-1784. PubMed ID: 30306296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial metabolites in health and disease: Navigating the unknown in search of function.
    Martinez KB; Leone V; Chang EB
    J Biol Chem; 2017 May; 292(21):8553-8559. PubMed ID: 28389566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an
    Carbajo-Pescador S; Porras D; García-Mediavilla MV; Martínez-Flórez S; Juarez-Fernández M; Cuevas MJ; Mauriz JL; González-Gallego J; Nistal E; Sánchez-Campos S
    Dis Model Mech; 2019 Apr; 12(5):. PubMed ID: 30971408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome and non-alcoholic fatty liver disease.
    Purohit A; Alam MJ; Kandiyal B; Shalimar ; Das B; Banerjee SK
    Prog Mol Biol Transl Sci; 2022; 191(1):187-206. PubMed ID: 36270678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microbiome-Host Interaction as a Potential Driver of Anastomotic Leak.
    Gershuni VM; Friedman ES
    Curr Gastroenterol Rep; 2019 Jan; 21(1):4. PubMed ID: 30684121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.